You are required to be logged in to access the full website
Click here if you have forgotten your username or password
15 October 2026 - KDventures AB (STO:KDV), a Nordic investment company focused on life sciences, disclosed on Thursday that portfolio company Modus Therapeutics has temporarily paused enrolment in Part 2 of its Phase 2a study evaluating sevuparin in ...
15 October 2026 - Dutch health technology company Royal Philips (NYSE:PHG) (AEX:PHIA) on Thursday announced the launch of EXIT-CVD, a five-year research initiative led by Philips and University Medical Center Groningen (UMCG) to advance how cardiovas...
15 October 2026 - Swedish medical technology company SciBase Holding AB (STO: SCIB), which develops AI-based dermatology assessment devices, said on Thursday it will participate in a new study led by the US National Institute of Health (NIH) in colla...
15 October 2026 - Clinical-stage biotechnology company Continuity Biosciences LLC announced on Wednesday that it has been awarded a grant of up to USD9.6m from the Gates Foundation to advance a subcutaneous, ultra-long-acting antiretroviral (ARV) imp...
15 October 2026 - Genezen, a gene therapy contract development and manufacturing organisation (CDMO), announced on Wednesday that it has entered into a manufacturing collaboration with Galibra Neuroscience, a biotechnology company developing transfor...
M2 Pharma brings you breaking news and information on the
global pharmaceuticals industry, helping you to stay one step ahead of the competition.
Click here to subscribe
Click here to subscribe